Search results
Pfizer Stock Gets Boost From Better-Than-Expected Earnings
Investopedia· 3 days agoNet income was 44% lower at $3.12 billion, or 55 cents per share from last year's mark of $5.54...
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
CNBC· 3 days agoThe company now expects to book adjusted earnings of $2.15 to $2.35 per share for the fiscal year,...
Pfizer Earnings Top Views; Boosts Full-Year Guidance
Market Watch· 3 days agoPfizer posted first-quarter earnings and sales that topped Wall Street targets and boosted its full-year projections as sales of blood thinners and cancer drugs helped shake ...
Pfizer lifts profit view on cost cuts, demand for COVID products
Reuters· 2 days agoSales of Padcev, a treatment for advanced bladder cancer Pfizer gained through its $43 billion deal...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks via Yahoo Finance· 3 days agoSI&A spending is expected...The adjusted tax rate is expected to be approximately 15% in 2024. Our...
Pfizer’s 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
Forbes· 3 days agoPfizer’s $0.55 diluted earnings per share and $14.9 billion in first-quarter sales smashed...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 2 days agoThe RS Rating measures a stock's 12-month running performance against all other stocks. That RS...
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To...
Benzinga via Yahoo Finance· 2 days agoOn Wednesday, Pfizer Inc. (NYSE:PFE) reported first-quarter adjusted EPS of $0.82, down 33% year...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 15 hours agoBut as society learned to live with Covid...reached a recent low at 2590.87 on April 25, down 15%...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 1 day ago12 a share. The company noted that it achieved 48% market share for Covid vaccines in the U.S....